Tacrolimus Starting Dose Prediction Based on Genetic Polymorphisms and Clinical Factors in Chinese Renal Transplant Recipients.

Wang, Peile; Zhang, Qiwen; Tian, Xueke; Yang, Jing; Zhang, Xiaojian

Wang, Peile; Zhang, Qiwen; Tian, Xueke; Yang, Jing; Zhang, Xiaojian.

Wang P; Department of Pharmacy, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Zhang Q; Henan Key Laboratory of Precision Clinical Pharmacy, Zhengzhou University, Zhengzhou, China.
Tian X; Department of Pharmacy, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Yang J; Henan Key Laboratory of Precision Clinical Pharmacy, Zhengzhou University, Zhengzhou, China.
Zhang X; Department of Pharmacy, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

Genet Test Mol Biomarkers ; 24(10): 665-673, 2020 Oct.

Article en En | MEDLINE | ID: mdl-32985896

Asunto(s)

Citocromo P-450 CYP3A/genética; Hemoglobinas/genética; Tacrolimus/administración & dosificación; Adulto; Alelos; Pueblo Asiatico; Biomarcadores Farmacológicos; China; Citocromo P-450 CYP3A/metabolismo; Femenino; Genotipo; Humanos; Inmunosupresores/administración & dosificación; Riñón/patología; Trasplante de Riñón/métodos; Masculino; Persona de Mediana Edad; Farmacogenética/métodos; Polimorfismo de Nucleótido Simple/genética; Tacrolimus/farmacocinética; Tacrolimus/uso terapéutico

Palabras clave

CYP3A5 genotype; Chinese renal transplant recipients; dosage prediction; hemoglobin; tacrolimus

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Hemoglobinas / Tacrolimus / Citocromo P-450 CYP3A Tipo de estudio: Guideline / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged País como asunto: Asia Idioma: En Año: 2020 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google